In vitro hepatic steatosis model based on gut-liver-on-a-chip
DC Field | Value | Language |
---|---|---|
dc.contributor.author | Jeon, Joong-Won | - |
dc.contributor.author | Lee, Seung Hwan | - |
dc.contributor.author | Kim, Donghyun | - |
dc.contributor.author | Sung, Jong Hwan | - |
dc.date.accessioned | 2021-09-02T04:41:18Z | - |
dc.date.available | 2021-09-02T04:41:18Z | - |
dc.date.created | 2021-03-11 | - |
dc.date.issued | 2021-05 | - |
dc.identifier.issn | 8756-7938 | - |
dc.identifier.uri | https://scholarworks.bwise.kr/hongik/handle/2020.sw.hongik/16161 | - |
dc.description.abstract | Hepatic steatosis, also known as fatty liver disease, occurs due to abnormal lipid accumulation in the liver. It has been known that gut absorption also plays an important role in the mechanism underlying hepatic steatosis. Conventional in vitro cell culture models have limitations in recapitulating the mechanisms of hepatic steatosis because it does not include the gut absorption process. Previously, we reported development of a microfluidic gut-liver chip that can recapitulate the gut absorption of fatty acids and subsequent lipid accumulation in liver cells. In this study, we performed a series of experiments to verify that our gut-liver chip reproduces various aspects of hepatic steatosis. The absorption of fatty acids was evaluated under various culture conditions. The anti-steatotic effect of turofexorate isopropyl (XL-335) and metformin was tested, and both drugs showed different action mechanisms. In addition, the oxidative stress induced by lipid absorption was evaluated. Our results demonstrate the potential of the gut-liver chip for use as a novel, physiologically realistic in vitro model to study fatty liver disease. | - |
dc.publisher | WILEY | - |
dc.title | In vitro hepatic steatosis model based on gut-liver-on-a-chip | - |
dc.type | Article | - |
dc.contributor.affiliatedAuthor | Sung, Jong Hwan | - |
dc.identifier.doi | 10.1002/btpr.3121 | - |
dc.identifier.scopusid | 2-s2.0-85099362443 | - |
dc.identifier.wosid | 000607719500001 | - |
dc.identifier.bibliographicCitation | BIOTECHNOLOGY PROGRESS, v.37, no.3 | - |
dc.relation.isPartOf | BIOTECHNOLOGY PROGRESS | - |
dc.citation.title | BIOTECHNOLOGY PROGRESS | - |
dc.citation.volume | 37 | - |
dc.citation.number | 3 | - |
dc.type.rims | ART | - |
dc.type.docType | Article | - |
dc.description.journalClass | 1 | - |
dc.description.journalRegisteredClass | scie | - |
dc.description.journalRegisteredClass | scopus | - |
dc.relation.journalResearchArea | Biotechnology & Applied Microbiology | - |
dc.relation.journalResearchArea | Food Science & Technology | - |
dc.relation.journalWebOfScienceCategory | Biotechnology & Applied Microbiology | - |
dc.relation.journalWebOfScienceCategory | Food Science & Technology | - |
dc.subject.keywordAuthor | fatty liver disease | - |
dc.subject.keywordAuthor | gut?liver-on-a-chip | - |
dc.subject.keywordAuthor | hepatic steatosis | - |
dc.subject.keywordAuthor | multi-organ-on-a-chip | - |
dc.subject.keywordAuthor | organ-on-a-chip | - |
Items in ScholarWorks are protected by copyright, with all rights reserved, unless otherwise indicated.
94, Wausan-ro, Mapo-gu, Seoul, 04066, Korea02-320-1314
COPYRIGHT 2020 HONGIK UNIVERSITY. ALL RIGHTS RESERVED.
Certain data included herein are derived from the © Web of Science of Clarivate Analytics. All rights reserved.
You may not copy or re-distribute this material in whole or in part without the prior written consent of Clarivate Analytics.